Page 10 - JCTR-10-2
P. 10

104                       Dinaki et al. | Journal of Clinical and Translational Research 2024; 10(2): 99-111
        follow-up lasted for 2.5 years without any incidents of deformation   muscular tissue of the vocal cords. Trauma, surgery, or long-term
        being  reported  [52].  In  2018,  a  7-year-old  patient  with  arrhinia   vocal misuse are the main causes of scar formation, leading to loss
        underwent nasal reconstruction using a 3D-printed nasal stent to   of pliability of the vocal folds. LP scarring causes stiffness and
        prevent nasal cavity constriction. In this clinical research, a custom-  reduces viscosity that changes the tissue biomechanics of the vocal
        made silicone nasal stent was manufactured utilizing 3D printing   fold [61]. As a result, the normal mucosa wave during phonation
        technology.  The  muco-epithelial  tissue  successfully  regenerated   is  disrupted,  thereby  affecting  the  vocals  [62,63].  Nonetheless,
        within  2  months  following  the  stent  placement.  External  nose   damaged vocal folds can be regenerated through several methods,
        shape, nasal passage structure, and respiratory functions were in   including cell therapy, developing and implementing a scaffold,
        good condition after 3 years following the stent removal without   and using growth factors.
        additional medical intervention [53].
          The most prominent use of auricular cartilage was in 1997 when   5.2. Cell therapy
        polyglycolic acid scaffolds were shaped into the 3D structure of a   Fibroblasts  and  stem  cells  are  extensively  studied  for  vocal
        human ear, seeded with bovine chondrocytes, and transplanted into   fold regeneration. Fibroblasts produce a large proportion of the
        the dorsal pockets of mice [54]. Thereafter, research was carried   extracellular matrix (ECM) in the LP and further support the LP.
        out in regenerative medicine with synthetic scaffolds and cultured   Fibroblasts resemble MSCs because they possess the same cell
        chondrocytes. Yanaga et al. injected a combination of autologous   surface markers and differentiation capacity [63]. Chhetri et al.
        serum and autologous chondrocytes from the outer ear cartilage   were the first to study the use of autologous fibroblasts from the
        into  the  ear,  nose,  and  chin  of  32  patients  with  craniofacial  or   buccal mucosa. In this study, fibroblasts were injected into the LP
        nasal abnormalities [49]. A two-stage transplantation procedure   of a canine model, subsequently improving the vocal fold mucosal
        was  performed  for  auricular  and  nasal/chin  reconstructions,   waves  and  acoustic  characteristics.  In  addition,  histological
        respectively  [55,56].  In  the  former,  chondrocytes  were  first   assessments revealed increased fibroblasts, collagen, and reticulin
        extracted  from  the  residual  auricular  cartilage  of  four  children   and decreased elastin [64]. Chhetri et al. also conducted a pilot
        with  microtia  and  cultivated  respectively  into  a  subcutaneous   study  where  five  individuals  with  damaged  vocal  folds  were
        pocket of fascia in the lower abdomen for 4 weeks. Subsequently,   injected with autologous fibroblasts from the buccal mucosa [65].
        the children did not report any adverse events during the 2- to   Four out of five patients demonstrated subjective and objective
        5-year follow-ups [55]. Similarly, 18 individuals were treated with   improvements in the vocal quality and mucosal wave. In another
        a comparable nasal/chin reconstructive technique [56].
                                                                study, Ma et al. examined the efficacy of fibroblasts in 15 patients
        4.7. Salivary glands                                    with  vocal  fold  scarring  or  atrophy  using  postauricular  skin-
                                                                derived autologous fibroblasts and reported improvements in the
          The  glands  of  the  upper  aerodigestive  tract  (i.e.,  parotid,   mucosal wave without any side effects [66].
        sublingual,  and  submandibular  glands)  and  minor  salivary   Likewise, BM-MSCs have demonstrated positive indications
        glands are known to produce saliva [57]. Hypofunctional can be   in animal studies [67,68]. In 2020, a phase I/II human clinical trial
        caused by radiation therapy for head and neck cancer, Sjogren’s   was  conducted  with  16  patients  to  investigate  the  treatment  of
        syndrome (SS), and various medications. Possible oral problems   vocal fold scarring with autologous BM-MSCs [69]. The patients
        caused by hyposalivation include mucosal infections, dysphagia,   were followed up for a year, and two-thirds of the participants
        and  aspiration  pneumonia.  In  animal  models,  BM-MCSs  have   demonstrated improvements in vocal vibration and flexibility.
        demonstrated the therapeutic  capability  to rebuild the salivary   There was another phase I/IIA clinical trial that demonstrated
        glands [58,59]. Xu et al. reported a successful restoration of the   the  efficacy  and  safety  of  adipose-derived  regenerative  cell-
        secretory  function  of  salivary  glands  in  animal  models  and  SS   enriched  fat  grafting  to  repair  glottal  gaps  following  unilateral
        patients  using  MSC  therapy  [58]. Adipose  tissue-derived  stem   vocal fold paralysis [70].
        cells (ASCs) have also been studied in clinical trials on irradiation-
        induced hypofunctional salivary glands in patients [60]. The phase   5.3. Bioactive factors
        I/II clinical trial evaluated the efficacy and safety of ASC-based
        cell therapy, whereby the submandibular glands were injected with   Hirano et al. studied the use of bFGF in treating atrophic human
        autologous ASCs. In the ACS-treated group, the unstimulated total   vocal fold. One week after the bFGF injection, the aerodynamic
        salivary flow rate (assessed after 1 and 4 months) was significantly   and acoustic parameters displayed improvements that lasted for
        more than the baseline (pre-treatment). In contrast, the placebo   3 months [71]. In a recent study by Hirano et al., local injections
        group reported a decrease in salivary flow rate after 1 month and a   of bFGF were performed in 100 cases of vocal fold disease [72].
        less prominent increase after 4 months.                 The findings of the study indicated that intracordal injection of
                                                                bFGF  resulted  in  voice  improvements  without  any  significant
        5. Applications in Laryngology                          adverse effects. Hirano et al. also reported that bFGF enhanced the
                                                                synthesis of HA in fibroblasts and decreased collagen deposition
        5.1. Vocal folds
                                                                in the vocal folds of aged rats [73]. Subsequently, Hirano et al.
          Lamina  propria  (LP)  is  a  flexible,  collagen-  and  elastin-rich   conducted  a  clinical  trial  with  10  patients  having  aged  vocal
        vibratory connective tissue layer between the epithelium and the   folds with scar tissue and sulcus vocalis [74]. The findings of the
                                                 DOI: https://doi.org/10.36922/jctr.22.00151
   5   6   7   8   9   10   11   12   13   14   15